Compound directory
16 of 50 compounds
Type
Goal
Tirzepatide
ProtocolGIP / GLP-1 dual agonist
- Start
- 2.5 mg
- Freq.
- Once weekly
- Vials
- 10 / 15 / 30 mg
Metabolic / Weight
Retatrutide
ProtocolGIP / GLP-1 / glucagon triple agonist
- Start
- 2 mg
- Freq.
- Once weekly
- Vials
- 10 / 20 / 30 mg
Metabolic / Weight
Semaglutide
ProtocolGLP-1 agonist
- Start
- 0.25 mg
- Freq.
- Once weekly
- Vials
- 3 / 5 / 10 mg
Metabolic / Weight
MOTS-c
Protocol- Start
- 5 mg
- Freq.
- 1–2× weekly
- Vials
- 10 / 40 mg
Metabolic / WeightLongevity
Cagrilintide
ProtocolLong-acting amylin analog
- Vials
- 5 mg
- Data
- Lab reference
Metabolic / Weight
AOD-9604
ProtocolhGH fragment 176-191 analog
- Vials
- 2 / 5 mg
- Data
- Lab reference
Metabolic / Weight
5-Amino-1MQ
ProtocolNNMT inhibitor
- Vials
- 10 / 50 mg
- Data
- Lab reference
Metabolic / Weight
AICAR
ProtocolAcadesine
- Vials
- 50 mg
- Data
- Lab reference
Metabolic / Weight
Cagrilintide + Semaglutide
BlendCagriSema
5 mg Cagrilintide · 5 mg Semaglutide
Per vial · verified against reference guide
- Vials
- 10 mg
- Data
- Lab reference
Metabolic / Weight
AOD-9604 + CJC-1295 + Ipamorelin
Blend6 mg AOD-9604 · 3 mg CJC-1295 · 3 mg Ipamorelin
Per vial · verified against reference guide
- Vials
- 12 mg
- Data
- Lab reference
Metabolic / WeightGrowth Hormone
SLU-PP-332
ProtocolERR agonist
- Vials
- 5 / 10 mg
- Data
- Lab reference
Metabolic / Weight
SS-31
ProtocolElamipretide
- Vials
- 10 / 50 mg
- Data
- Lab reference
LongevityMetabolic / Weight
Survodutide
ProtocolGLP-1 / glucagon dual agonist
- Vials
- 10 / 20 mg
- Data
- Lab reference
Metabolic / Weight
Tesofensine
Protocol- Vials
- 10 mg
- Data
- Lab reference
Metabolic / Weight
Cagrilintide + Tirzepatide
Stack- Vials
- 10 mg
- Data
- Lab reference
Metabolic / Weight
Cagrilintide + Retatrutide
Stack- Vials
- 10 mg
- Data
- Lab reference
Metabolic / Weight